Clever Leaves Holdings Inc. Stock News

Alan Brochstein's 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective informa

Ascend Wellness Promotes Frank Perullo To President Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH) has promoted its co-founder and chief strategy officer, Frank Perullo, to president. At h

Ascend Wellness Promotes Frank Perullo To President Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH ) has promoted its co-founder and chief strategy officer, Frank Perullo, to president. At his new position, Perullo will be responsible for AWH''s day-to-day operations with the retail, sales and marketing as well as operations departments will report directly to Perullo going forward, in addition to his existing reports, the company said Monday. Abner Kurtin, founder and CEO of AWH will continue to lead the company and oversee Perullo, along with Dan Neville, chief financial officer, and Robin Debiase, chief people officer. “I can''t think of a better person to step into the President role than Frank, as we further develop our canopy, brand portfolio, and retail footprint in 2022 and beyond," Kurtin said. "He will be a crucial asset as we enter our next stage of growth, where we will focus on expanding our product offering and national footprint to better serve our patients and customers." MedMen’s CRO Tracy McCourt Resigns Cannabis retailer MedMen Enterprises Inc. (OTC: MMNFF ) announced on Monday that Tracy McCourt, the company''s chief revenue officer opted to resign, effective March 4. "We appreciate Tracy''s contributions to the organization these past …

Clever Leaves Holdings Inc. (NASDAQ: CLVR ) announced an expansion of its relationship with Australian medical cannabis company Cannatrek Ltd. by signing a two-year, take-or-pay basis supply agreement . The deal includes high-THC flower from Portugal, while expanding on its existing partnership for various 10% and 20% CBD oral solutions from Colombia announced in 2020. Licensed to distribute and sell to Australian medical cannabis patients, Cannatrek has been offering 10% and 20% CBD oral solutions supplied by Clever Leaves since 2020. Broadening the reach of both companies in Australia’s thriving market, Clever Leaves will now provide a strain of … Full story available on Benzinga.com

Clever Leaves (CLVR) has broadened its collaboration with the Australian medical cannabis company Cannatrek after the duo agreed to a new supply deal.The two-year, take-or-pay basis

The agreement will now include high-THC Flower from Portugal facilities and will allow for the expansion of its oral solution supply The agreement will now include high-THC Flower from Portugal facili

Clever Leaves Holdings Inc. (NASDAQ:CLVR) announced an expansion of its relationship with Australian medical cannabis company Cannatrek Ltd. by signing a two-year, take-or-pay basis supply agreement.

Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents Schumer Urges Senators To Help Finalize Marijuana Legalization Bill No

Clever Leaves Holdings Inc. (NASDAQ: CLVR ) reported its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021, along with its 2022 outlook. Q4 2021 Financial Estimates vs. Same Year-Ago Quarter Revenue is expected to increase 25% to approximately $4.2 million compared to $3.3 million. Gross profit is expected to increase 5% to approximately $2.4 million compared to $2.3 million, with a gross margin of approximately 56.8% compared to 67.9%. Net loss is expected to range between approximately $17.1 million and $17.5 million compared to $0.9 million. Adjusted EBITDA (a non-GAAP number defined and reconciled herein) is expected to come in negative and range between approximately $(7.3) million and $(7.7) million compared to $(6.3) million. At December 31, 2021, the company’s cash, cash equivalents, and restricted cash are expected to be approximately $37 million compared to $79.5 million. Full Year 2021 Financial Estimates vs. 2020: Revenue is expected to increase 27% to approximately $15.4 million compared to $12.1 …

Clever Leaves Holdings (CLVR) has appointed director and president Andres Fajardo to succeed Kyle Detwiler as CEO, effective March 24, 2022.Until then, Detwiler will remain CEO and

Clever Leaves Holdings Inc. CLVR reported its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021, along with its 2022 outlook. Q4 2021 Financial Estim

Appointment Accompanied by One-Year Lock-Up for Schultze Special Purpose Acquisition Sponsor Shares Appointment Accompanied by One-Year Lock-Up for Schultze Special Purpose Acquisition Sponsor Shares

MGO (Macias Gini and O’Connell LLP), a leader in accounting, tax, audit and advisory solutions for the cannabis and hemp industries has released its 3rd annual “Cannabis 50” list. The list high

Clever Leaves Holdings Inc. (NASDAQ: CLVR), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced Wednesday that it has officially entered the U.S. CBD market

JOYSOL™, a CBD brand developed by Clever Leaves’ US consumer packaged goods division, Herbal Brands, is now available online JOYSOL™, a CBD brand developed by Clever Leaves’ US consumer packag